BOLD vs PSA · P/E 0.1, $24.6M cap vs rev $4.82B
Boundless Bio, Inc. Common Stock (BOLD) versus PSA (PSA) — a side-by-side from cached financials, not a winner call.
Boundless Bio, Inc. Common Stock (BOLD) is a biotechnology company listed on US.
PSA (PSA) common stock.
BOLD does not have a complete income-statement cache yet.
Latest reported PSA revenue for 2025-12-31 was $4.82B. Net income was $1.78B. Revenue was up 2.7% from 2024-12-31 to 2025-12-31. PSA currently screens at market cap $0.
BOLD currently screens at market cap $24.6M and trailing P/E 0.1. PSA currently screens at market cap $0.
Not investment advice. Open the BOLD and PSA stock pages for the full models.
Not investment advice.